The U.S. Food and Drug Administration (FDA) is developing a new electronic information system to improve drug and medical product monitoring, Government Computer News reports. Called the Sentinel System, the data-mining technology will enable the FDA to collect information about medical products by querying electronic health records, patient registry data, insurance claims data and other major health care information databases. Specifically, the technology will link Medicare drug claims to other Medicare information on patient care such as hospitalizations and physician visits, and the collected information will become available to other federal agencies, state Medicaid programs, researchers and beneficiaries for their personal health records. According to GCN, "the technology will be created through public/private partnerships and capitalize on large, existing electronic claims and medical records data sources maintained by private and government entities that agree to participate." In addition, it will enable the FDA to analyze significantly more information and detect early signs of emerging safety problems. Created in conjunction with the federal Centers for Medicare and Medicaid Services, the project ultimately aims to identify possible post-market adverse health events to improve patient care nationwide (Hickey, GCN, 5/27/08).